http://www.unboundmedicine.com/medline/ebm/research/nelfinavirUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19925397/full_citation/Effects_of_Antiretroviral_Drug_Recall_on_Perception_of_Therapy_Benefits_and_on_Adherence_to_Antiretroviral_Treatment_in_HIV_Infected_Children_Giannattasio A, Barbarino A, Lo Vecchio A, et al. 
Effects of Antiretroviral Drug Recall on Perception of Therapy Benefits and on Adherence to Antiretroviral Treatment in HIV-Infected Children. [JOURNAL ARTICLE]
Curr HIV Res 2009 Sep; 7(5):468-472.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19916992/full_citation/Influence_of_CYP2C19_polymorphism_on_the_pharmacokinetics_of_nelfinavir_and_its_active_metabolite_Damle BD, Uderman H, Biswas P, et al. 
Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Nov; 68(5):682-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19915448/full_citation/Postpartum_antiretroviral_drug_resistance_in_HIV_1_infected_women_receiving_pregnancy_limited_antiretroviral_therapy_Paredes R, Cheng I, Kuritzkes DR, et al. 
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy. [JOURNAL ARTICLE]
AIDS 2009 Nov 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890215/full_citation/CYP2C19_Genetic_Variants_Affect_Nelfinavir_Pharmacokinetics_and_Virologic_Response_in_HIV_1_Infected_Children_Receiving_Highly_Active_Antiretroviral_Therapy_Saitoh A, Capparelli E, Aweeka F, et al. 
CYP2C19 Genetic Variants Affect Nelfinavir Pharmacokinetics and Virologic Response in HIV-1-Infected Children Receiving Highly Active Antiretroviral Therapy. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Nov 3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19866516/full_citation/The_Viracept_EMS_case:_impact_and_outlook_Walker VE, Casciano DA, Tweats DJ 
The Viracept-EMS case: impact and outlook. [Journal Article, Research Support, Non-U.S. Gov't]
Toxicol Lett 2009 Nov 12; 190(3):333-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19862765/full_citation/Effects_of_obesity_induced_by_high_fat_diet_on_the_pharmacokinetics_of_nelfinavir_a_HIV_protease_inhibitor_in_laboratory_rats_Sugioka N, Haraya K, Fukushima K, et al. 
Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats. [JOURNAL ARTICLE]
Biopharm Drug Dispos 2009 Oct 27.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19857797/full_citation/In_vivo_genotoxicity_of_EMS:_Statistical_assessment_of_the_dose_response_curves_Gocke E, Wall M 
In vivo genotoxicity of EMS: Statistical assessment of the dose response curves. [JOURNAL ARTICLE]
Toxicol Lett 2009 Nov 12; 190(3):298-302.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19857796/full_citation/Literature_review_on_the_genotoxicity_reproductive_toxicity_and_carcinogenicity_of_ethyl_methanesulfonate_Gocke E, Bürgin H, Müller L, et al. 
Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate. [JOURNAL ARTICLE]
Toxicol Lett 2009 Nov 12; 190(3):254-265.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19857795/full_citation/What_happened:_The_chemistry_side_of_the_incident_with_EMS_contamination_in_Viracept_tablets_Gerber C, Toelle HG 
What happened: The chemistry side of the incident with EMS contamination in Viracept tablets. [JOURNAL ARTICLE]
Toxicol Lett 2009 Nov 12; 190(3):248-253.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19857794/full_citation/EMS_in_Viracept_The_course_of_events_in_2007_and_2008_from_the_non_clinical_safety_point_of_view_Müller L, Singer T 
EMS in Viracept-The course of events in 2007 and 2008 from the non-clinical safety point of view. [JOURNAL ARTICLE]
Toxicol Lett 2009 Nov 12; 190(3):243-247.
Abstract | Full Citation